Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're using Mounjaro for weight management and going to the gym, you don't need to choose between them — but the combination does raise practical questions worth understanding before you rearrange your schedule. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist prescribed for adults managing their weight alongside a reduced-calorie diet and increased physical activity. Exercise is already built into the licence. What matters is how you time it, fuel it, and adjust it as your dose changes — and that's exactly what this page covers. As a prescription-only medicine, Mounjaro requires a clinical assessment before a prescriber can issue it; it isn't available to buy without one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1, which slow gastric emptying, increase feelings of fullness, and reduce appetite between meals. For most people that's the point. But those same effects change how training feels in ways that aren't always obvious at first.
Slower gastric emptying means food sits in your stomach longer than usual. Training hard on a recently eaten meal can feel uncomfortable, nausea and bloating are more likely than they'd have been before you started treatment. Hunger cues, which you might previously have used as a rough guide to pre-workout fuelling, become unreliable. You may arrive at the gym having eaten far less than your body actually needs to perform.
Fatigue is also reported by some people, particularly in the early weeks or after a dose step. The NHS tirzepatide patient information page lists tiredness among the common side effects. That's worth knowing if you've been wondering why a session that used to feel easy suddenly doesn't.
None of this means stopping exercise, quite the opposite. It means reading your body more carefully than before, and adjusting timing rather than effort.
Mounjaro is a once-weekly injection. Side effects, when they occur, tend to peak in the 24–48 hours after the jab, particularly nausea and fatigue. Most people find a rhythm where injection day (and the day after) is kept clear of anything high-intensity, and harder training sits towards the middle or end of the week when those effects have passed.
There's no clinical rule about which day to inject, but consistency matters: the pen should be taken on the same day each week, stored properly (refrigerated between 2–8°C, which many people tuck into the fridge door alongside daily items they'll remember), and injected at roughly the same time. If a dose is missed or you're unsure about timing around travel or a gym competition, the Patient Information Leaflet and your prescriber are the right sources, not general forums.
Cardio tends to be more forgiving around injection day than weightlifting, because the intensity ceiling is easier to manage. Heavy compound lifts on a queasy stomach rarely go well. Save those for later in the week.
For more on how Mounjaro fits alongside other health considerations, the Mounjaro and HRT page covers how absorption questions arise in similar practical contexts.
This is the step most people underestimate. Significant weight loss (including the kind seen in Mounjaro trials, where participants lost around 20% of body weight on average over 72 weeks in SURMOUNT-1) inevitably includes some loss of lean mass alongside fat. That proportion worsens if protein intake falls too low and there's no stimulus to maintain muscle.
Mounjaro's appetite suppression makes it easy to eat very little, which feels like a success in the short term. The problem is that a diet consistently low in protein, combined with a large calorie deficit, accelerates muscle loss. Muscle matters for metabolic rate, joint health, long-term weight maintenance, and how you actually look and feel when weight comes off.
Resistance training (weights, machines, bodyweight work) gives your muscles a reason to stay. It doesn't need to mean competitive powerlifting; two or three sessions a week of progressive resistance work is enough to make a meaningful difference. Protein targets are a conversation for your prescriber or a registered dietitian, since they depend on your starting weight, activity level and health history. The general principle: eat enough protein at each meal, even when you're not hungry, and don't skip it because appetite is low.
The full Mounjaro overview covers eligibility and the broader clinical picture if you're still deciding whether treatment is right for you.
Dehydration risks rise with Mounjaro for two reasons: GI side effects (nausea, loose stools, vomiting) can cause fluid loss, and reduced appetite often means reduced drinking as well. Exercise adds a third reason. The combination matters because even mild dehydration affects performance, recovery and the way side effects feel.
Practical habit: keep a water bottle in your gym bag and drink to a schedule rather than waiting for thirst. On days when nausea is present, cold still water is usually easier to tolerate than hot drinks or anything flavoured.
Dizziness is worth paying attention to, particularly during exercise. It can reflect dehydration, or a bigger calorie deficit than intended, or simply the adjustment period in the early weeks of treatment. If dizziness is frequent or severe, that's a conversation for your prescriber, not something to push through at the squat rack.
People using Mounjaro alongside other conditions sometimes ask about interactions. The Mounjaro and IBS page addresses one common overlap, and Mounjaro and MS covers another situation where exercise capacity and treatment interact in specific ways.
If you're considering Mounjaro costs as part of your decision, that page gives an honest breakdown of what private treatment involves. And if you're ready to start, a free consultation with our prescribers is the right first step, clinical assessment determines whether Mounjaro is suitable for you specifically.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.